mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
NI

Novartis India Limited

NSE:EVONILEBSE:EVONILE
HealthcarePharmaceuticals & Biotechnology
₹1,568.1
-15.93%11 Nov close
Mkt cap
₹3,873 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&OFund holdersDocumentsEventsAnnouncementsNotes
AnnualQuarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
808656564491438381400379335356354
COGS345306246199182147-178-202-200-203—
Gross profit463350318292256235—————
440325325280244208551515470468263
Operating profit (EBITDA)2425-61212272765659194
OPM %2.9%3.8%-1.1%2.5%2.8%7%6.8%17.2%19.5%25.7%26.6%
Depreciation44331312106322
Interest01626852111
83711727836833358624239
Profit before tax—92158862940-4115123130130
Tax783579341919-012383036
Tax %—37.6%50.3%39.6%64.8%47.8%-2.6%10.4%30.7%22.6%28.1%
1995778521021-41038510193
PAT margin %24.6%8.7%13.9%10.6%2.3%5.5%-0.9%27.3%25.4%28.3%26.3%
EPS (₹)——————-1.541.934.52937.8
EPS adjusted (₹)62.120.331.8214.18.5-1.541.934.540.9—
———————113.5%72.4%86.2%—
Annual reportAnnual report for Mar 2016Annual report for Mar 2017Annual report for Mar 2018Annual report for Mar 2019Annual report for Mar 2020Annual report for Mar 2021Annual report for Mar 2022Annual report for Mar 2023Annual report for Mar 2024Annual report for Mar 2025Annual report for Mar 2026

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity capital16141212121212121212
Reserves1,017906721747708699679763732773
———————010
206230377223357291266207179163
Total equity & liabilities1,2391,1501,1119821,0781,002958983925948
86515129—221
CWIP0—————————
Investments——————————
1,2301,1441,1069671,066993958981923947
Total assets1,2391,1501,1119821,0781,002958983925948

₹ CrMar 2019Mar 2020Mar 2021Mar 2024Mar 2025
-194-23-6911375
Cash from investing274569533-3
Cash from financing-30-41-37-121-64
Net cash flow—-9-11267
Free cash flow—————
CFO / Operating profit %—-192.4%-258.3%173.9%81.6%

Compounded sales growth

7 years
-5%
5 years
-2%
3 years
-2%
1 year
-1%

Compounded profit growth

7 years
9%
5 years
35%
3 years
-3%
1 year
-8%

Stock price CAGR

10 years
—
5 years
16%
3 years
34%
1 year
83%

Return on equity

7 years
7%
5 years
8%
3 years
13%
Last year
13%